Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06660225Not ApplicableRecruiting

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

Role: lead

NCT05936619Not ApplicableRecruiting

MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System

Role: lead

NCT03952962Not ApplicableRecruiting

Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression

Role: lead

NCT02438033Phase 1Withdrawn

Characterizing the Specificity and Stability of Local Field Potentials in the Globus Pallidus Internus of Patients Undergoing Deep Brain Stimulation for Parkinson's Disease

Role: lead

All 4 trials loaded